UNSPSC 85653030: Supplement right foot muscle with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right foot muscle with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0KUV47Z

UNSPSC 85653030 Supplement right foot muscle with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent state and local procurement activity. The six recent opportunities posted under this code—spanning independent medical evaluations for public safety pension boards, surgical benefit carve-outs for municipal employee health plans, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing—address administrative health services, benefits administration, and clinical staffing, none of which align with the orthopedic surgical procedure the code nominally describes. The mismatch between the code's clinical scope and the actual opportunities suggests either data-classification error in the sourcing system or incidental tagging unrelated to the code's intended commodity domain.

The issuing bodies reflect typical municipal and county health-administration purchasing: the City of Phoenix Retirement Office, the City of Long Beach, the Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and the County of Santa Clara Health System. Geographic activity spans Arizona, California, Washington, Texas, and Florida. No opportunities directly procure the orthopedic surgical procedure or tissue-substitute service the code nominally covers; accordingly, firms pursuing state and local contracts in orthopedic or tissue-engineering domains should verify classification against actual RFPs before committing pursuit resources, as this code does not currently surface relevant work.